. I think phase 2 is the earliest stage of trial. It’s another drug targeting CGRP, but what makes it interesting is that it directly targets the...
Crossed with Chris P I don't claim expertise, but do know that the SNP identified is rarely the active, relevant DNA difference. Usually, it is...
In his large study of glandular fever, Peter White found that days of bedrest was a predictor of developing CFS. Bedrest is most obviously a...
From a recent review on LC: The impact of vaccination on long COVID symptoms in people who had already developed long COVID differs among...
Joshua was working in Chris Ponting’s group, and his PhD was jointly funded by Action for. ME and the office of the Scottish chief medical...
If I’ve understood right, using best practice mathematical and immunological methods, Joshua did find a single genetic difference that was...
Thank you, I’m glad the issue will be clearly raised. Like many others, I’ve achieved that short term gain under the encouragement of a...
I know you and Adrian do, but unless the research group absolutely locks in subjective outcome measures to use only in blinded trials, I think the...
Thanks. I would much prefer objective measures. but does the research group understand the prolem of using subjective outcomes in non-blinded trials?
It would be helpful to know the purpose of using the sf-36 scale. and apologies if this is posted earlier, I haven't been able to read the whole...
SF-36 Physical Function subscale I actually think the SF 36 scale provides the best available self-report measure of physical function (I'm not...
I’m not sure that such hypothesising based on a large number of generic symptoms gets us anywhere useful. It’s easy to fit just about any...
edited I feel I and others with severe ME have a lot to offer ME research projects. At no point in my illness could I have ever done 4 hours, but...
@FMMM1 The approach uses combinations of features (in this case between three and 5 SNPs) to create “disease signatures“ that identify a subgroup...
Key section from the published paper. There are a number of limitations with this study discussed above, and a larger, more detailed longitudinal...
The full paper has now been peer-reviewed and published (open access). Genetic risk factors for ME/CFS identified using combinatorial analysis...
The approach of the Edinburgh Genetics Centre of Excellence and aim of DecodeME is the first find genetic clues pointing to the causes of ME....
Has this been published yet? It would be good to have more detail. E.g. anything over 3 months to recovery I woulc call a relapse. But I am...
Despite being in the field for at leat a decade, CPET researchers are still failing to collect and publish harms data. That is as unacceptable for...
I think this is the first specific study looking at ethnic differences, which is is a very important area. but I'm not sure how much we can...
Separate names with a comma.